OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of agomelatine on adult hippocampus apoptosis and neurogenesis using the stress model of rats
Atakan Yücel, Nermin Yücel, Seçkin Özkanlar, et al.
Acta Histochemica (2016) Vol. 118, Iss. 3, pp. 299-304
Closed Access | Times Cited: 25

Showing 25 citing articles:

The antioxidant role of agomelatine and gallic acid on oxidative stress in STZ induced type I diabetic rat testes
Gürkan Yiğittürk, Ahmet Çağdaş Acara, Oytun Erbaş, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 87, pp. 240-246
Closed Access | Times Cited: 76

Sleep and hippocampal neurogenesis: Implications for Alzheimer’s disease
Brianne A. Kent, Ralph E. Mistlberger
Frontiers in Neuroendocrinology (2017) Vol. 45, pp. 35-52
Closed Access | Times Cited: 53

Benefits of the Neurogenic Potential of Melatonin for Treating Neurological and Neuropsychiatric Disorders
Yaiza Potes, Cristina Cachán-Vega, Eduardo Antuña, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4803-4803
Open Access | Times Cited: 16

Mechanisms and Therapeutic Targets of Depression After Intracerebral Hemorrhage
Yinan Wu, Liangliang Wang, Kaimin Hu, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 44

<p>Melatonin receptor stimulation by agomelatine prevents A&beta;-induced tau phosphorylation and oxidative damage in PC12 cells</p>
Kai Yao, Yongfei Zhao, Hengbing Zu
Drug Design Development and Therapy (2019) Vol. Volume 13, pp. 387-396
Open Access | Times Cited: 38

Protective Effects of Melatonin on Neurogenesis Impairment in Neurological Disorders and Its Relevant Molecular Mechanisms
Joseph Wai-Hin Leung, Kwok‐Kuen Cheung, Shirley P.C. Ngai, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5645-5645
Open Access | Times Cited: 37

Agomelatine effects on fat-enriched diet induced neuroinflammation and depression-like behavior in rats
Redouane Rebai, Luc Jasmin, Abdennacer Boudah
Biomedicine & Pharmacotherapy (2021) Vol. 135, pp. 111246-111246
Open Access | Times Cited: 29

Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative disease
Jin‐Shun Qi, Qiang Su, Tian Li, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 4, pp. 727-727
Open Access | Times Cited: 20

Night shift hormone: How does melatonin affect depression?
Gita Kholghi, Maliheh Eskandari, Mohammad-Saleh Shokouhi Qare Saadlou, et al.
Physiology & Behavior (2022) Vol. 252, pp. 113835-113835
Closed Access | Times Cited: 19

Melatonin produces a rapid onset and prolonged efficacy in reducing depression-like behaviors in adult rats exposed to chronic unpredictable mild stress
Xiaoran Sun, Mengting Wang, Yiqiang Wang, et al.
Neuroscience Letters (2017) Vol. 642, pp. 129-135
Closed Access | Times Cited: 31

Agomelatine prevents indomethacin-induced gastric ulcer in rats
Ersen Eraslan, Ayhan Tanyeli̇, Mustafa Can Güler, et al.
Pharmacological Reports (2020) Vol. 72, Iss. 4, pp. 984-991
Closed Access | Times Cited: 22

Agomelatine attenuates calcium signaling and apoptosis via the inhibition of TRPV1 channel in the hippocampal neurons of rats with chronic mild stress depression model
Güli̇n Özdamar Ünal, Arif Demirdaş, Mustafa Nazıroğlu, et al.
Behavioural Brain Research (2022) Vol. 434, pp. 114033-114033
Closed Access | Times Cited: 13

Behavioral Abnormality Induced by Enhanced Hypothalamo-Pituitary-Adrenocortical Axis Activity under Dietary Zinc Deficiency and Its Usefulness as a Model
Atsushi Takeda, Haruna Tamano, Ryusuke Nishio, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 7, pp. 1149-1149
Open Access | Times Cited: 16

Protective effects of agomelatine on testicular damage caused by bortezomib
Nurhan Akaras, Tuğba Bal, Hilal Atilay, et al.
Biotechnic & Histochemistry (2017) Vol. 92, Iss. 8, pp. 552-559
Closed Access | Times Cited: 14

High-dose Agomelatine Combined with Haloperidol Decanoate Improves Cognition, Downregulates MT2, Upregulates D5, and Maintains Krüppel-like Factor 9 But Alters Cardiac Electrophysiology
Sherine Abdelmissih, Marwa Abdelgwad, Doaa Mohamed Elroby Ali, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 390, Iss. 1, pp. 125-145
Open Access | Times Cited: 1

Agomelatine: An Astounding Sui-generis Antidepressant?
Jing Zhang, Qigang Zhou, Muhammad Naveed, et al.
Current Molecular Pharmacology (2021) Vol. 15, Iss. 7, pp. 943-961
Closed Access | Times Cited: 9

Exploring the Potential Molecular Mechanism of the Shugan Jieyu Capsule in the Treatment of Depression through Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
Zhiyao Liu, Hailiang Huang, Ying Yu, et al.
Current Computer - Aided Drug Design (2023) Vol. 20, Iss. 5, pp. 501-517
Closed Access | Times Cited: 3

Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations
Ayse Irem Sonmez, Ammar Almorsy, Laura B. Ramsey, et al.
Depression and Anxiety (2020) Vol. 37, Iss. 8, pp. 747-759
Open Access | Times Cited: 8

Can melatonin improve the alteration of protein synthesis occurring in schizophrenia and bipolar disorder?
Ana Coto‐Montes, Nerea Menéndez-Coto, José Antonio Boga
Melatonin Research (2023) Vol. 6, Iss. 1, pp. 51-58
Open Access | Times Cited: 2

Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression
Susanne Englisch, Hanna Sophie Jung, Sarah Eisenacher, et al.
Journal of Clinical Psychopharmacology (2018) Vol. 38, Iss. 4, pp. 357-361
Closed Access | Times Cited: 5

Baicalin Coadministration with Lithium Chloride Enhanced Neurogenesis <i>via</i> GSK3β Pathway in Corticosterone Induced PC-12 Cells
Zhe Wang, Yating Cheng, Ye Lu, et al.
Biological and Pharmaceutical Bulletin (2022) Vol. 45, Iss. 5, pp. 605-613
Open Access | Times Cited: 3

Agomelatine – pharmacological properties and use in psychiatric practice
Marcin Siwek, A Wasik, Anna Julia Krupa
Psychiatria i Psychologia Kliniczna (2019) Vol. 19, Iss. 2, pp. 188-203
Open Access | Times Cited: 3

The Effects of Fluoxetine and Agomelatine on Neurocognitive Functions and Sleep in Patients with Major Depressive Disorder
Esat Fahri Aydın, M. Gulec, Elif Oral, et al.
Psychiatry and Clinical Psychopharmacology (2024) Vol. 34, Iss. 1, pp. 9-18
Open Access

Efficacy and Safety of Agomelatine in Depressed Patients with Diabetes: A Systematic Review and Meta-Analysis
Adam Gędek, Szymon Modrzejewski, Michał Materna, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12631-12631
Open Access

Agomelatyna w ocenie farmakologa i neurologa – bezpieczeństwo i zastosowanie kliniczne
Monika Białecka
Neuropsychiatria Przegląd Kliniczny (2021) Vol. 13, Iss. 1-2, pp. 6-14
Open Access | Times Cited: 1

Page 1

Scroll to top